Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Structural mechanism of Myb-MuvB assembly.

Guiley KZ, Iness AN, Saini S, Tripathi S, Lipsick JS, Litovchick L, Rubin SM.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):10016-10021. doi: 10.1073/pnas.1808136115. Epub 2018 Sep 17.

2.

The Drosophila LIN54 homolog Mip120 controls two aspects of oogenesis.

Cheng MH, Andrejka L, Vorster PJ, Hinman A, Lipsick JS.

Biol Open. 2017 Jul 15;6(7):967-978. doi: 10.1242/bio.025825.

3.

The role of variant histone H2AV in Drosophila melanogaster larval hematopoiesis.

Grigorian M, DeBruhl H, Lipsick JS.

Development. 2017 Apr 15;144(8):1441-1449. doi: 10.1242/dev.142729. Epub 2017 Feb 27.

4.

Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.

Barasch N, Gong X, Kwei KA, Varma S, Biscocho J, Qu K, Xiao N, Lipsick JS, Pelham RJ, West RB, Pollack JR.

PLoS One. 2017 Feb 17;12(2):e0171265. doi: 10.1371/journal.pone.0171265. eCollection 2017.

5.

The complex containing Drosophila Myb and RB/E2F2 regulates cytokinesis in a histone H2Av-dependent manner.

DeBruhl H, Wen H, Lipsick JS.

Mol Cell Biol. 2013 May;33(9):1809-18. doi: 10.1128/MCB.01401-12. Epub 2013 Feb 25.

6.

Duplication and maintenance of the Myb genes of vertebrate animals.

Davidson CJ, Guthrie EE, Lipsick JS.

Biol Open. 2013 Feb 15;2(2):101-10. doi: 10.1242/bio.20123152. Epub 2012 Nov 6.

7.

Epigenetic regulation of olfactory receptor gene expression by the Myb-MuvB/dREAM complex.

Sim CK, Perry S, Tharadra SK, Lipsick JS, Ray A.

Genes Dev. 2012 Nov 15;26(22):2483-98. doi: 10.1101/gad.201665.112. Epub 2012 Oct 26.

8.

Drosophila lin-52 acts in opposition to repressive components of the Myb-MuvB/dREAM complex.

Lewis PW, Sahoo D, Geng C, Bell M, Lipsick JS, Botchan MR.

Mol Cell Biol. 2012 Aug;32(16):3218-27. doi: 10.1128/MCB.00432-12. Epub 2012 Jun 11.

9.

Animal-specific C-terminal domain links myeloblastosis oncoprotein (Myb) to an ancient repressor complex.

Andrejka L, Wen H, Ashton J, Grant M, Iori K, Wang A, Manak JR, Lipsick JS.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17438-43. doi: 10.1073/pnas.1111855108. Epub 2011 Oct 3.

10.

MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.

West RB, Kong C, Clarke N, Gilks T, Lipsick JS, Cao H, Kwok S, Montgomery KD, Varma S, Le QT.

Am J Surg Pathol. 2011 Jan;35(1):92-9. doi: 10.1097/PAS.0b013e3182002777.

11.

The C-MYB story--is it definitive?

Lipsick JS.

Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17067-8. doi: 10.1073/pnas.1012402107. Epub 2010 Sep 21. No abstract available.

12.

A conserved acidic patch in the Myb domain is required for activation of an endogenous target gene and for chromatin binding.

Ko ER, Ko D, Chen C, Lipsick JS.

Mol Cancer. 2008 Oct 7;7:77. doi: 10.1186/1476-4598-7-77.

13.

Epigenetic regulation of gene expression by Drosophila Myb and E2F2-RBF via the Myb-MuvB/dREAM complex.

Wen H, Andrejka L, Ashton J, Karess R, Lipsick JS.

Genes Dev. 2008 Mar 1;22(5):601-14. doi: 10.1101/gad.1626308.

14.

Loss of Drosophila Myb interrupts the progression of chromosome condensation.

Manak JR, Wen H, Van T, Andrejka L, Lipsick JS.

Nat Cell Biol. 2007 May;9(5):581-7. Epub 2007 Apr 22.

PMID:
17450131
15.

Myb proteins inhibit fibroblast transformation by v-Rel.

Fu SL, Ganter B, Lipsick JS.

Mol Cancer. 2006 Nov 2;5:54.

16.

v-Myb represses the transcription of Ets-2.

Wang DM, Sevcikova S, Wen H, Roberts S, Lipsick JS.

Oncogene. 2007 Feb 22;26(8):1238-44. Epub 2006 Aug 14.

PMID:
16909100
17.

synMuv verite--Myb comes into focus.

Lipsick JS.

Genes Dev. 2004 Dec 1;18(23):2837-44. Review. No abstract available.

18.

Functional evolution of the vertebrate Myb gene family: B-Myb, but neither A-Myb nor c-Myb, complements Drosophila Myb in hemocytes.

Davidson CJ, Tirouvanziam R, Herzenberg LA, Lipsick JS.

Genetics. 2005 Jan;169(1):215-29. Epub 2004 Oct 16.

19.

Fluorescence-activated cell sorting (FACS) of Drosophila hemocytes reveals important functional similarities to mammalian leukocytes.

Tirouvanziam R, Davidson CJ, Lipsick JS, Herzenberg LA.

Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2912-7. Epub 2004 Feb 19.

20.

Role for a Drosophila Myb-containing protein complex in site-specific DNA replication.

Beall EL, Manak JR, Zhou S, Bell M, Lipsick JS, Botchan MR.

Nature. 2002 Dec 19-26;420(6917):833-7.

PMID:
12490953
21.

Mutation of the Drosophila homologue of the Myb protooncogene causes genomic instability.

Manak JR, Mitiku N, Lipsick JS.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7438-43.

22.

Mutational analysis of the transcriptional activation domains of v-Myb.

Wang DM, Lipsick JS.

Oncogene. 2002 Feb 28;21(10):1611-5.

23.

Functional evolution of the Myb oncogene family.

Lipsick JS, Manak J, Mitiku N, Chen CK, Fogarty P, Guthrie E.

Blood Cells Mol Dis. 2001 Mar-Apr;27(2):456-8.

PMID:
11259167
24.

BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb.

Ladendorff NE, Wu S, Lipsick JS.

Oncogene. 2001 Jan 4;20(1):125-32.

25.

Transcriptional activation by the myb proteins requires a specific local promoter structure.

Ganter B, Chao ST, Lipsick JS.

FEBS Lett. 1999 Nov 5;460(3):401-10. Review.

26.

Transformation by v-Myb.

Lipsick JS, Wang DM.

Oncogene. 1999 May 13;18(19):3047-55. Review.

28.

Functional analysis of carboxy-terminal deletion mutants of c-Myb.

Wang DM, Dubendorff JW, Woo CH, Lipsick JS.

J Virol. 1999 Jul;73(7):5875-86.

29.

Myb and oncogenesis.

Ganter B, Lipsick JS.

Adv Cancer Res. 1999;76:21-60. Review. No abstract available.

PMID:
10218098
31.

Myb-related Schizosaccharomyces pombe cdc5p is structurally and functionally conserved in eukaryotes.

Ohi R, Feoktistova A, McCann S, Valentine V, Look AT, Lipsick JS, Gould KL.

Mol Cell Biol. 1998 Jul;18(7):4097-108. Erratum in: Mol Cell Biol 1998 Oct;18(10):6164.

32.
33.

Myb binding sites within the N-ras promoter repress transcription.

Ganter B, Lipsick JS.

Oncogene. 1997 Jul 10;15(2):193-202.

34.
36.

FAETL motif required for leukemic transformation by v-Myb.

Fu SL, Lipsick JS.

J Virol. 1996 Aug;70(8):5600-10.

37.

One billion years of Myb.

Lipsick JS.

Oncogene. 1996 Jul 18;13(2):223-35. Review.

PMID:
8710361
38.

Dissociation of transcriptional activation and oncogenic transformation by v-Myb.

Chen RH, Fields S, Lipsick JS.

Oncogene. 1995 Nov 2;11(9):1771-9.

PMID:
7478605
39.

By-pass of TPA-induced differentiation and cell cycle arrest by the c-Myb DNA-binding domain.

Engelke U, Smarda J, Lipsick JS.

Oncogene. 1995 Aug 17;11(4):735-41.

PMID:
7651737
40.

Weak transcriptional activation is sufficient for transformation by v-Myb.

Engelke U, Whittaker L, Lipsick JS.

Virology. 1995 Apr 20;208(2):467-77.

41.
43.
44.

Dicistronic selection for nuclear proteins in living animal cells.

Smarda J, Lipsick JS.

Gene. 1993 Dec 27;137(1):145-9.

PMID:
8282197
45.
46.
47.

c-Myb and v-Myb are differentially phosphorylated by p42mapk in vitro.

Aziz N, Wu J, Dubendorff JW, Lipsick JS, Sturgill TW, Bender TP.

Oncogene. 1993 Aug;8(8):2259-65.

PMID:
8336948
48.
49.

Carboxy-terminal elements of c-Myb negatively regulate transcriptional activation in cis and in trans.

Dubendorff JW, Whittaker LJ, Eltman JT, Lipsick JS.

Genes Dev. 1992 Dec;6(12B):2524-35.

50.

Protein truncation is not required for c-myb proto-oncogene activity in neuroretina cells.

Garrido C, Grässer F, Lipsick JS, Stehelin D, Saule S.

J Virol. 1992 Nov;66(11):6773-6.

Supplemental Content

Loading ...
Support Center